Angiopoietin-like protein ANGPTL2 gene expression is correlated with lymph node metastasis in lung cancer

Oncology Letters

Volumn 4, Issue 6, 2012, Pages 1325-1328

  Sasaki, Hidefumi ^a   Suzuki, Ayumi ^a   Shitara, Masayuki ^a   Hikosaka, Yu ^a   Okuda, Katsuhiro ^a   Moriyama, Satoru ^a   Yano, Motoki ^a   Fujii, Yoshitaka ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Angiopoietin; ANGTL2; LightCycler; Lung cancer; Metastasis

Indexed keywords

ANGIOPOIETIN 2; ANGIOPOIETIN LIKE PROTEIN 2; BETA ACTIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER SURGERY; CARCINOGENESIS; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SMOKING;

EID: 84867261767     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.924     Document Type: Article

References (24)

1. Ginsberg RJ, Kris MK and Armstrong G (eds): Cancer of the lung. In: Principles and Practice of Oncology. 4th edition. Lippincott, Philadelphia, pp673-682, 1993.
2. Sakata R, Fujii Y and Kuwano H: Thoracic and cardiovascular surgery in Japan during 2009: annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 59: 636-667, 2011.
3. Postmus PE: Chemotherapy for non-small cell lung cancer: the experience of the Lung Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. Chest 113: 28S-31S, 1998.
4. Grivennikov SI, Greten FR and Karin M: Immunity, inflammation, and cancer. Cell 140: 883-899, 2010.
5. de Martel C and Franceschi S: Infections and cancer: established associations and new hypotheses. Crit Rev Oncol Hematol 70: 183-194, 2009.
6. Takahashi H, Takahashi I, Honma M, et al: Prevalence of metabolic syndrome in Japanese psoriasis patients. J Dermatol Sci 57: 143-144, 2010.
7. Destert C, Petrilli V, Van Bruggen R, et al: Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320: 674-677, 2008.
8. Kant P and Hull MA: Excess body weight and obesity-the link with gastrointestinal and hepatobilliary cancer. Nat Rev Gastroenterol Hepatol 8: 224-238, 2011.
9. Tabata M, Kadomatsu T, Fukuhara S, et al: Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab 10: 178-188, 2009.
10. Bi M, Naczki C, Koritzinsky M, et al: ER stress-regulated translation increases torelance to extreme hypoxia and promotes tumor growth. EMBO J 24: 3470-3481, 2005.
11. Aoi J, Endo M, Kadomatsu T, et al: Angiopoietin-like protein 2 is an important facilitator of inflammatory carcinogenesis and metastasis. Cancer Res 71: 7502-7512, 2011.
12. Kikuchi R, Tsuda H, Kozaki K, et al: Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer. Cancer Res 68: 5067-5075, 2008.
13. Endo M, Nakano M, Kadomatsu T, et al: Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis. Cancer Res 72: 1784-1794, 2012.
14. Teicher BA: Searching for molecular targets in sarcoma. Biochem Pharmacol 84: 1-10, 2012.
15. Wittwer CT, Ririe KM, Andrew RV, et al. The LightCycler: a microvolume multi sample fluorimeter with rapid temperature control. Biotechniques 22: 176-181, 1997.
16. Ogata A, Endo M, Aoi J, et al: The role of angiopoietin-like protein 2 in pathogenesis of dermatomyositis. Biochem Biophys Res Commun 418: 494-499, 2012.
17. Tazume H, Miyake K, Tian Z, et al: Macropage-derived angiopoietin-like protein 2 accelerates development of abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 32: 1400-1409, 2012.
18. Colotta F, Allavena P, Sica A, et al: Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30: 1073-81, 2009.
19. Kadomatsu T, Tabata M and Oike Y: Angiopoietin-like proteins: emerging targets for treatment of obesity and related metabolic disease. FEBS J 278: 559-564, 2011.
20. Tabata M, Kadomatsu T, Fukuhara S, et al: Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab 10: 178-188, 2009.
21. Zheng JY, Zou JT, Wang WZ, et al: Tumor necrosis factor-α a increases angiopoietin-like 2 gene expression by activating Foxo1 in 3T3-L1 adipocytes. Mol Cell Endocrinol 339: 120-129, 2011.
22. Kitazawa M, Nagono M, Masumoto KH, et al: Angiopoietin-like 2, a circadian gene, improves type 2 diabetes through potentiation of insulin sensitivity. Endocrinology 152: 2558-2567, 2011.
23. Kim I, Moon SO, Koh KN, et al: Molecular cloning, expression, and characterization of angiopoietin-related protein. Angiopoietin-related protein induces endothelial cell spouting. J Biol Chem 274: 26523-26528, 1999.
24. Oike Y, Ito Y, Maekawa H, et al: Angiopoietin-related growth factor (AGF) promotes angiogenesis. Blood 103: 3760-3765, 2004.